Cancer incidence among children in France, 1990–1999

Abstract

The estimated incidence rates are similar to those reported in previous studies in European and North American countries. These results will contribute to the development of National Registration of Childhood Cancer in France and support the national research program on childhood cancer.

Birth characteristics and childhood malignant central nervous sytem tumors: The ESCALE study (French Society for Childhood Cancer)

“…Congenital malformations have decreased in France since 1995, thanks to active prevention (folate supplementation) and early screening for major CNS malformations such as spina bifida, enabling therapeutic abortion [14]. (1) Non-conditional logistic regression adjusted on age and gender, (2) …”

“…In France, about 200 new cases of malignant CNS tumours are diagnosed each year [2]. Most of the cases emerge before the age of 5 years, suggesting that antenatal, perinatal, or early postnatal exposures may be considered potential risk factors [3].…”

“…Non-conditional logistic regression adjusted on age and gender; (2) Non-conditional polytomic regression adjusted on age and gender;…”

Evaluation of the Histo-Epidemiological Profile of Solid Childhood Cancers in Togo

“…Are considered child malignant solid tumors (TSME) all cancers, excluding leukemias (Bergeron and Philip, 2004). In France, they represent less than 0.6% of all cancers and yet are the leading cause of child death after accidental causes (Desandes et al, 2004). Moreover, despite significant treatment advances, the disease and its treatments can cause significant squeal and handicaps on a growing organism (Desandes et al, 2004).…”

Overview of Carcinomas in Adolescents: A Descriptive Study Over Twenty Years

“…Whereas most tumors in adults are epithelial tumors, carcinomas are rare in patients under 20 years of age, and account for 9% of all childhood cancers between 10 and 14 years and 20% in patients aged 15-19 years [1,2]. In the SEER (National Cancer Institute's Surveillance, Epidemiology and End Results) registry, the carcinoma incidence rate in 2008-2012 was 12 between 10 and 14 years, and 44.6 between 15 and 19 years, per million (age-adjusted to the 2000 US standard population) [1].…”